ES2274614T3 - Uso de un agente antimicrobiano, tal como la taurolidina o el taurultam, para preparar un medicamento para el tratamiento de una infeccion microbiana nosocomial. - Google Patents

Uso de un agente antimicrobiano, tal como la taurolidina o el taurultam, para preparar un medicamento para el tratamiento de una infeccion microbiana nosocomial. Download PDF

Info

Publication number
ES2274614T3
ES2274614T3 ES99900217T ES99900217T ES2274614T3 ES 2274614 T3 ES2274614 T3 ES 2274614T3 ES 99900217 T ES99900217 T ES 99900217T ES 99900217 T ES99900217 T ES 99900217T ES 2274614 T3 ES2274614 T3 ES 2274614T3
Authority
ES
Spain
Prior art keywords
taurolidine
use according
resistant
taurultam
strains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99900217T
Other languages
English (en)
Spanish (es)
Inventor
Rolf Pfirrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Application granted granted Critical
Publication of ES2274614T3 publication Critical patent/ES2274614T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
ES99900217T 1998-01-08 1999-01-06 Uso de un agente antimicrobiano, tal como la taurolidina o el taurultam, para preparar un medicamento para el tratamiento de una infeccion microbiana nosocomial. Expired - Lifetime ES2274614T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4063 1998-01-08
US09/004,063 US5972933A (en) 1998-01-08 1998-01-08 Method of treating microbial infections

Publications (1)

Publication Number Publication Date
ES2274614T3 true ES2274614T3 (es) 2007-05-16

Family

ID=21708954

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99900217T Expired - Lifetime ES2274614T3 (es) 1998-01-08 1999-01-06 Uso de un agente antimicrobiano, tal como la taurolidina o el taurultam, para preparar un medicamento para el tratamiento de una infeccion microbiana nosocomial.

Country Status (8)

Country Link
US (1) US5972933A (enExample)
EP (1) EP1044006B1 (enExample)
JP (2) JP2002500189A (enExample)
AU (1) AU757294B2 (enExample)
CA (1) CA2317748C (enExample)
DE (1) DE69934294T2 (enExample)
ES (1) ES2274614T3 (enExample)
WO (1) WO1999034805A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117868A (en) * 1998-09-16 2000-09-12 Ed. Geistlich Sohne Ag Fur Chemische Industrie Treatment of gastrointestinal ulcers or gastritis caused by microbial infection
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
JP2003515558A (ja) * 1999-12-06 2003-05-07 ロード アイランド ホスピタル， ア ライフスパン パートナー 腫瘍を治療するためのメチロール含有化合物の使用
US20020004502A1 (en) * 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
WO2003028642A2 (en) 2001-10-01 2003-04-10 Rhode Island Hospital, A Lifespan Partner Methods of inhibiting metastases
US7240441B2 (en) * 2004-02-12 2007-07-10 Mccoy Ted Excavator thumb for use with excavator equipment
ES2377206T3 (es) 2006-01-06 2012-03-23 Ed Geistlich Sohne Ag Fur Chemische Industrie Composiciones irradiadas y tratamiento de cánceres con radiación en combinación con taurolidina y/o taurultam
US20080008734A1 (en) * 2006-07-05 2008-01-10 Perrault James J Reduction of skin irritation caused by biomedical electrodes
WO2011097646A1 (en) * 2010-02-08 2011-08-11 Maxlinear, Inc. Methods and apparatus for intelligent power reduction in communications systems
CN103118669B (zh) * 2010-06-01 2016-01-13 盖斯特里希医药公司 口服药物治疗方法和组合物
US20130296223A1 (en) * 2012-03-30 2013-11-07 Sciclone Pharmaceuticals, Inc. Use of thymosin alpha for the treatment of sepsis
WO2014089226A1 (en) 2012-12-04 2014-06-12 The Board Of Trustees Of The University Of Illinois Antibacterial compounds targeting isoprenoid biosynthesis
CA3000868C (en) * 2015-10-07 2025-02-04 Cormedix Inc. SKIN PENETRATION FORMULATION BASED ON TAUROLIDINE
WO2018129061A1 (en) * 2017-01-05 2018-07-12 Cormedix Inc. Antimicrobial delivery system for the prevention and treatment of infections in the colon

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
GB1557163A (en) * 1975-06-24 1979-12-05 Geistlich Soehne Ag Dental care preparations
US4107305A (en) * 1975-08-04 1978-08-15 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Treatment of endotoxaemia
US4002889A (en) * 1975-12-08 1977-01-11 Servo Corporation Of America Self-cleaning label for automatic object identification system
US4337251A (en) * 1979-05-09 1982-06-29 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of avoiding and removing adhesions
CA1190855A (en) * 1980-09-03 1985-07-23 Rolf W. Pfirrmann Treatment of osteitis
GB8328111D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
GB8328074D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compositions
GB8328073D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
DE3506288A1 (de) * 1984-09-06 1986-03-13 Johannes 7900 Ulm Reinmüller Vorrichtung zum einlegen in wunden und wundhoehlen
GB8424518D0 (en) * 1984-09-28 1984-11-07 Geistlich Sohne Af Fur Chemisc Chemical compounds
GB8514055D0 (en) * 1985-06-04 1985-07-10 Geistlich Soehne Ag Chemical substance
DE3533612A1 (de) * 1985-09-20 1987-04-02 Johannes Reinmueller Neuartige verwendung von taurolin
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
GB8813033D0 (en) * 1988-06-02 1988-07-06 Geistlich Soehne Ag Chemical compound
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
GB8827986D0 (en) * 1988-11-30 1989-01-05 Geistlich Soehne Ag Chemical product
CA2031803C (en) * 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
GB9005856D0 (en) * 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
US5187082A (en) * 1990-08-16 1993-02-16 Eli Lilly And Company Process for producing A83850 antibiotics
DK0589893T3 (da) * 1991-04-15 1996-09-09 Applied Microbiology Inc Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
DE69104608T2 (de) * 1991-07-04 1995-02-16 Weissenfluh Hawe Neos Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis.
GB9216155D0 (en) * 1992-07-30 1992-09-09 Geistlich Soehne Ag Treatment of dentoalveolar infections
US5650320A (en) * 1994-04-20 1997-07-22 University Of Alabama At Birmingham Research Foundation Lanthionine antibiotic compositions and methods
GB9600426D0 (en) * 1996-01-10 1996-03-13 Ed Geistlich Sohne A G Compositions
CA2244421A1 (en) * 1996-01-16 1997-07-24 Advanced Polymer Systems, Inc. Topical delivery of drugs to the lower gastrointestinal tract

Also Published As

Publication number Publication date
AU757294B2 (en) 2003-02-13
JP2002500189A (ja) 2002-01-08
AU1884499A (en) 1999-07-26
EP1044006B1 (en) 2006-12-06
DE69934294T2 (de) 2007-07-05
US5972933A (en) 1999-10-26
JP2010174032A (ja) 2010-08-12
JP5469511B2 (ja) 2014-04-16
CA2317748C (en) 2008-07-08
EP1044006A1 (en) 2000-10-18
DE69934294D1 (de) 2007-01-18
CA2317748A1 (en) 1999-07-15
WO1999034805A1 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
JP5469511B2 (ja) 微生物の院内感染症の治療用医薬の製造におけるタウロリジンまたはタウラルタムのような抗微生物薬剤の使用
ES2565564T3 (es) Una composición que comprende un antibiótico y un dispersante
US8697639B2 (en) Compositions and methods for treating bacteria
ES2339003T3 (es) Rifalazil para tratar infecciones por clostridium difficile.
JP2755550B2 (ja) ヘリコバクター・ピロリに起因する胃性消化不良を治療するためのリファキシミンを含有する医薬製剤
JP5410748B2 (ja) 抗菌剤およびカルベオール、チモール、オイゲノール、ボルネオールならびにカルバクロールから選択される活性成分を含んでなる医薬組成物
JP2002525266A (ja) 感染性潰瘍又は胃炎に対するタウロリジン及び／又はタウルルタム
JP2002500189A5 (enExample)
Gałązka et al. Ecthyma gangrenosum as a serious complication of Pseudomonas aeruginosa infection in departments of pediatric oncology
Ramos et al. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci
US20070185026A1 (en) Compositions and methods for treating bacteria
ES2428167T3 (es) Composición farmacéutica bactericida activa anti-MRSA conteniendo carbapenemos
Levison et al. Increasing antimicrobial resistance: therapeutic implications for enterococcal infections
CN1285745A (zh) 酶前体药物作为抗感染剂的应用
US20070009566A1 (en) Method and apparatus for treating bacterial infections in devices
CN101426507A (zh) 多聚氨基酸与抗生素的联合使用
Dixit et al. Comparative evaluation of antimicrobial efficacy of various intracanal medicament in young permanent teeth: An in vivo study
ES2308975T3 (es) Fibras endodonticas y sus procedimientos de uso.
US20030096766A1 (en) Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria
US20210369675A1 (en) Antimicrobial drug methods of use & therapeutic compositions
PT1458391E (pt) Um processo para tratamento de infecções bacterianas através do uso de gemifloxacina ou um seu sal e um antibiótico b-lactâmico
Hopefl Aztreonam—an overview
EP3862001A1 (en) Anti-helicobacter agent and method for the use thereof
Labu et al. Glimpse of usage of antimicrobial agents and its unwanted effects
US20060270648A1 (en) Use of polyamines with antibiotics